Chronic Chagas Disease in the Brazilian Amazon: Serological Survey, Clinical Follow-Up, and Associated Risk Factors
Authors:
- Laise Kelma Costa MagalhãesLMLaise Kelma Costa Magalhães
- Laylah Kelre Costa MagalhãesLMLaylah Kelre Costa Magalhães
- Suzane Ribeiro PrestesSPSuzane Ribeiro Prestes
- Alba Regina Jorge BrandãoABAlba Regina Jorge Brandão
- Emily de Sousa MouraEMEmily de Sousa Moura
- Elsa Isela Guevara MoctezumaEMElsa Isela Guevara Moctezuma
- Monica Regina Hosanahh da Silva E SilvaMSMonica Regina Hosanahh da Silva E Silva
- Katia Do Nascimento CouceiroKCKatia Do Nascimento Couceiro
- Yuliana Padrón-AntonioYPYuliana Padrón-Antonio
- Victor Irungu MwangiVMVictor Irungu Mwangi
- Jessica Vanina OrtizJOJessica Vanina Ortiz
- 4 June 2025
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (6) , 1220-1228
Abstract
: The prevalence and characteristics of chronic Chagas disease (CCD) in the Amazon Region remain underexplored. This study aimed to describe the challenges encountered during a serological survey and follow-up of CCD, while also highlighting potential risk factors in the Amazon Region. The serological survey involved residents of periurban and rural areas of Manaus in the Brazilian Amazon. All participants were invited to complete a clinical, epidemiological, and demographic questionnaire and provide a blood sample for anti-Trypanosoma cruzi (T. cruzi) IgG tests. A total of 1,845 participants were included, of whom 43 were identified as having presumed CCD, based on having at least two positive serological tests. Only 35 underwent complementary tests, and five had cardiac alterations not consistent with CCD. The main risk factors associated with CCD were age ≥20 years, living in periurban areas, reporting the presence of the insect vector inside the household, entering the forest, consumption of bushmeat, and having undergone blood transfusion. In the Amazon, the population is exposed to the sylvatic T. cruzi life cycle and is unaware of the associated risk factors. The divergent serology results raise doubts about the reliability of the commercial serological tests used for CCD screening in the region. Surveillance for CCD is important in the Amazon.Keywords
This publication has 19 references indexed in Scilit:
- Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas diseaseMemórias do Instituto Oswaldo Cruz, 2022
- Geographic Variations in Test Reactivity for the Serological Diagnosis of Trypanosoma cruzi InfectionJournal of Clinical Microbiology, 2021
- Bioecological aspects of triatomines and marsupials as wild Trypanosoma cruzi reservoirs in urban, peri‐urban and rural areas in the Western Brazilian AmazonMedical and Veterinary Entomology, 2021
- Driving forces for strengthening the surveillance of Chagas disease in the Brazilian Amazon by “training the eyes” of malaria microscopistsRevista da Sociedade Brasileira de Medicina Tropical, 2020
- Evolution of Chagas’ disease in Brazil. Epidemiological perspective and challenges for the future: a critical reviewPerspectives in Public Health, 2016
- Chagas disease in the State of Amazonas: history, epidemiological evolution, risks of endemicity and future perspectivesRevista da Sociedade Brasileira de Medicina Tropical, 2015
- Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian AmazonParasites & Vectors, 2014
- Trypanosoma cruzi I and IV Stocks from Brazilian Amazon Are Divergent in Terms of Biological and Medical Properties in MicePLOS Neglected Tropical Diseases, 2013
- Trypanosoma cruzi IV Causing Outbreaks of Acute Chagas Disease and Infections by Different Haplotypes in the Western Brazilian AmazoniaPLOS ONE, 2012
- Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania sppClinical and Vaccine Immunology, 2007